Related Experiment Video

Updated: Aug 14, 2026

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

Parvovirus B19: a new emerging pathogenic agent of inflammatory cardiomyopathy

C T Bock1

  • 1Department of Molecular Pathology, Institute of Pathology, University Hospital of Tübingen, Germany. thomas.bock@med.uni-tuebingen.de

Ernst Schering Research Foundation Workshop
|December 7, 2005
PubMed

Insights

Human parvovirus B19 (PVB19) causes inflammatory cardiomyopathy by infecting heart endothelial cells. This viral infection leads to endothelial dysfunction and myocardial inflammation in both children and adults.

Area of Science:

  • Virology
  • Cardiology
  • Pathology

Background:

  • Human parvovirus B19 (PVB19) is the sole known pathogenic human parvovirus, causing various clinical outcomes.
  • PVB19 is increasingly recognized as a cause of inflammatory cardiac diseases in pediatric and adult populations.

Purpose of the Study:

  • To elucidate the role of PVB19 infection in the development of cardiac dysfunction.
  • To characterize the mechanisms underlying PVB19-associated inflammatory cardiomyopathy.

Main Methods:

  • In situ hybridization (ISH) to detect viral presence within cardiac tissues.
  • Polymerase chain reaction (PCR) to identify PVB19 DNA in cardiac samples.

Main Results:

  • PVB19 infection targets endothelial cells in small intracardiac vessels.
  • Evidence suggests PVB19 infection contributes to endothelial dysfunction and impaired myocardial microcirculation.

Conclusions:

  • PVB19 is an etiological agent in inflammatory cardiomyopathy.
  • The pathogenesis involves endothelial cell infection, leading to myocardial inflammation and dysfunction.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...